Top 10 OTC & Nutraceuticals markets in Saudi Arabia

The fastest-growing and largest of the 41 sized OTC & Nutraceuticals markets in Saudi Arabia, 2023 to 2033, with active clinical trials.

Fastest-growing OTC & Nutraceuticals markets in Saudi Arabia

Top 10 fastest-growing OTC & Nutraceuticals markets in Saudi Arabia, by CAGR 2023 to 2033
#Market20232033 (projected)CAGRActive trials
1 Cannabidiol (CBD) Supplements $90 Mn$484 Mn 18.3%0
2 Prebiotics $138 Mn$480 Mn 13.3%1
3 Beauty Supplements $70 Mn$193 Mn 10.7%3
4 Coenzyme Q10 $9 Mn$23 Mn 10.5%0
5 Adaptogens $138 Mn$357 Mn 10%0
6 Mood and Stress Supplements $179 Mn$446 Mn 9.6%1
7 Plant-Based Supplements $209 Mn$518 Mn 9.5%0
8 Sports Nutrition $884 Mn$2.2 Bn 9.4%1
9 Herbal Supplements $1.4 Bn$3.3 Bn 9.1%0
10 Omega 3 Fatty Acid $70 Mn$164 Mn 8.9%1

Largest OTC & Nutraceuticals markets in Saudi Arabia

Top 10 largest OTC & Nutraceuticals markets in Saudi Arabia, by 2023 size
#Market20232033 (projected)CAGRActive trials
1 Nutritional Supplements $6.5 Bn$14.5 Bn 8.3%7
2 Dietary Supplements $5.2 Bn$11 Bn 7.7%7
3 Functional Food $4.8 Bn$10.7 Bn 8.2%3
4 Over The Counter (OTC) Drugs $3 Bn$5.5 Bn 6.2%0
5 Over The Counter (OTC) Pharmaceuticals $3 Bn$5.5 Bn 6.2%0
6 Over The Counter (OTC) Consumer $2.6 Bn$4.9 Bn 6.7%0
7 Herbal Supplements $1.4 Bn$3.3 Bn 9.1%0
8 Sports Nutrition $884 Mn$2.2 Bn 9.4%1
9 Over The Counter (OTC) Vitamins and Minerals $544 Mn$1.1 Bn 7%1
10 Clinical Nutrition $485 Mn$1.1 Bn 8.6%6

2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.

Quick answers

What is the fastest-growing OTC & Nutraceuticals market in Saudi Arabia?

Cannabidiol (CBD) Supplements grows fastest, at 18.3% a year from 2023 to 2033, ahead of Prebiotics (13.3%).

What is the largest OTC & Nutraceuticals market in Saudi Arabia?

Nutritional Supplements is the largest, worth about $6.5 Bn in 2023 and $14.5 Bn by 2033 (projected).

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.